Olof Heimbürger
#143,999
Most Influential Person Now
Swedish researcher
Olof Heimbürger's AcademicInfluence.com Rankings
Olof Heimbürgerchemistry Degrees
Chemistry
#3747
World Rank
#4787
Historical Rank
Analytical Chemistry
#153
World Rank
#160
Historical Rank

Download Badge
Chemistry
Olof Heimbürger's Degrees
- PhD Chemistry Stockholm University
Why Is Olof Heimbürger Influential?
(Suggest an Edit or Addition)Olof Heimbürger's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. (1999) (1706)
- IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly. (2005) (847)
- Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). (2000) (820)
- Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? (2008) (553)
- Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. (2006) (500)
- Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. (2002) (473)
- Associations between circulating inflammatory markers and residual renal function in CRF patients. (2003) (408)
- Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. (2002) (396)
- Impact of inflammation on epigenetic DNA methylation – a novel risk factor for cardiovascular disease? (2007) (379)
- Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. (2014) (350)
- Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. (1990) (343)
- Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. (2005) (343)
- Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. (2003) (338)
- Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. (2007) (276)
- Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. (2001) (262)
- Hand-grip muscle strength, lean body mass, and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy. (2000) (262)
- Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients. (2008) (245)
- Nutritional status in dialysis patients: a European consensus. (2002) (244)
- Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. (2006) (232)
- Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite. (2007) (231)
- Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. (2002) (227)
- Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease (2016) (225)
- Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6? (2002) (224)
- Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. (1997) (218)
- Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? (2002) (216)
- J-shaped mortality relationship for uric acid in CKD. (2006) (216)
- Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. (1998) (210)
- Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality. (2008) (209)
- A comparative analysis of nutritional parameters as predictors of outcome in male and female ESRD patients. (2002) (208)
- Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients. (2000) (201)
- Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: association with Chlamydia pneumoniae seropositivity. (2002) (197)
- Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. (2000) (194)
- Truncal fat mass as a contributor to inflammation in end-stage renal disease. (2004) (193)
- Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus. (2005) (190)
- Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. (2004) (189)
- Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease. (2000) (181)
- A quantitative description of solute and fluid transport during peritoneal dialysis. (1992) (177)
- Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease (2007) (175)
- Low serum testosterone increases mortality risk among male dialysis patients. (2009) (170)
- Telomere attrition is associated with inflammation, low fetuin‐A levels and high mortality in prevalent haemodialysis patients (2008) (170)
- Calculation of the Protein Equivalent of Total Nitrogen Appearance from Urea Appearance. Which Formulas Should be Used? (1998) (168)
- Low leptin gene expression and hyperleptinemia in chronic renal failure. (1998) (168)
- Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality. (2007) (166)
- Aqueous solute concentrations and evaluation of mass transport coefficients in peritoneal dialysis. (1992) (158)
- Serum albumin as predictor of nutritional status in patients with ESRD. (2012) (155)
- When to start dialysis: updated guidance following publication of the Initiating Dialysis Early and Late (IDEAL) study. (2011) (153)
- Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease. (2011) (148)
- Physical activity and energy expenditure in haemodialysis patients: an international survey. (2012) (146)
- Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. (2001) (145)
- Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min). (2015) (140)
- Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. (2003) (139)
- Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy. (2003) (138)
- A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients. (2003) (133)
- Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD. (2016) (133)
- Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis. (2010) (127)
- Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD. (2007) (127)
- Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease. (2008) (124)
- Adipose tissue and its relation to inflammation: the role of adipokines. (2005) (121)
- Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study. (2004) (121)
- Genetic and clinical factors influence the baseline permeability of the peritoneal membrane. (2005) (118)
- Do ACE‐inhibitors suppress tumour necrosis factor‐α production in advanced chronic renal failure? (1999) (116)
- Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients. (2009) (115)
- Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival. (2009) (115)
- European best practice guidelines for peritoneal dialysis. 3 Peritoneal access. (2005) (110)
- Influence of Peritoneal Transport Rate, Inflammation, and Fluid Removal on Nutritional Status and Clinical Outcome in Prevalent Peritoneal Dialysis Patients (2003) (109)
- Malnutrition, Inflammation, and Atherosclerosis in Peritoneal Dialysis Patients (2001) (109)
- Systemic and Intraperitoneal Interleukin-6 System during the First Year of Peritoneal Dialysis (2006) (108)
- Chronic Inflammation in Peritoneal Dialysis: The Search for the Holy Grail? (2004) (105)
- Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure. (1997) (103)
- Educating end-stage renal disease patients on dialysis modality selection: clinical advice from the European Renal Best Practice (ERBP) Advisory Board. (2010) (101)
- Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease. (2012) (97)
- Wasting, but not malnutrition, predicts cardiovascular mortality in end-stage renal disease. (2004) (97)
- Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease. (2005) (93)
- A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients. (1998) (87)
- A quantitative analysis of sodium transport and removal during peritoneal dialysis. (1997) (86)
- The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease (2018) (86)
- Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD. (2005) (84)
- Dialysate to plasma solute concentration (D/P) versus peritoneal transport parameters in CAPD. (1994) (83)
- Evaluation of peritoneal membrane characteristics: clinical advice for prescription management by the ERBP working group. (2010) (83)
- Soluble leptin receptors and serum leptin in end‐stage renal disease: relationship with inflammation and body composition (2002) (82)
- Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients. (2009) (82)
- Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patients. (2010) (81)
- Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease. (2012) (80)
- Simple models for description of small-solute transport in peritoneal dialysis. (1991) (78)
- Fat tissue accumulation during peritoneal dialysis is associated with a polymorphism in uncoupling protein 2. (2000) (77)
- European best practice guidelines for peritoneal dialysis. 7 Adequacy of peritoneal dialysis. (2005) (77)
- Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure. (1998) (76)
- Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-α are similarly associated with survival in haemodialysis patients. (2011) (75)
- The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation. (2006) (74)
- Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship? (2010) (73)
- Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD. (2006) (73)
- Alterations in Water and Solute Transport with Time on Peritoneal Dialysis (1999) (73)
- European best practice quo vadis? From European Best Practice Guidelines (EBPG) to European Renal Best Practice (ERBP). (2008) (70)
- Peritonitis in Continuous Ambulatory Peritoneal Dialysis (CAPD): Diagnostic Findings, Therapeutic Outcome and Complications (1989) (70)
- High serum hyaluronan indicates poor survival in renal replacement therapy. (1999) (69)
- The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality. (2008) (67)
- Effect of increased dialysate fill volume on peritoneal fluid and solute transport. (1997) (66)
- Lipoprotein(a) in nephrotic syndrome. (1993) (66)
- Baseline levels and trimestral variation of triiodothyronine and thyroxine and their association with mortality in maintenance hemodialysis patients. (2012) (65)
- Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy. (2004) (65)
- Soluble adhesion molecules in end-stage renal disease: a predictor of outcome. (2006) (65)
- Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease. (2004) (64)
- Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality (2003) (64)
- High-flux or low-flux dialysis: a position statement following publication of the Membrane Permeability Outcome study. (2010) (64)
- Longitudinal relationships between fluid status, inflammation, urine volume and plasma metabolites of icodextrin in patients randomized to glucose or icodextrin for the long exchange. (2008) (64)
- Does a High Peritoneal Transport Rate Reflect a State of Chronic Inflammation? (1999) (63)
- Experimental models in peritoneal dialysis: a European experience. (1998) (63)
- Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose. (1996) (60)
- Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients. (2011) (60)
- Does statins promote vascular calcification in chronic kidney disease? (2017) (59)
- Lyphatic absorption in CAPD patients with loss of ultrafiltration capacity. (1995) (58)
- Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy. (2002) (58)
- Dialysis modality choice in diabetic patients with end-stage kidney disease: a systematic review of the available evidence. (2015) (57)
- Editorial: Poor Outcomes for Fast Transporters on PD: The Rise and Fall of a Clinical Concern (2007) (56)
- Clinical global assessment of nutritional status as predictor of mortality in chronic kidney disease patients (2017) (56)
- Enhanced RAGE-mediated NFκB stimulation in inflamed hemodialysis patients (2005) (56)
- Elevated Serum Macrophage Migration Inhibitory Factor (MIF) Concentrations in Chronic Kidney Disease (CKD) Are Associated with Markers of Oxidative Stress and Endothelial Activation (2009) (56)
- Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal disease. (2011) (55)
- Systemic inflammation in dialysis patients with end-stage renal disease: causes and consequences. (2004) (55)
- Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus. (2003) (55)
- Low serum fetuin‐A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients (2008) (55)
- Diffusive mass transport coefficients are not constant during a single exchange in continuous ambulatory peritoneal dialysis. (1996) (54)
- Osmotic Conductance of the Peritoneum in Capd Patients with Permanent Loss of Ultrafiltration Capacity (1996) (53)
- Clinical importance of an elevated circulating chemerin level in incident dialysis patients. (2010) (52)
- Clinical determinants of reduced physical activity in hemodialysis and peritoneal dialysis patients (2015) (51)
- Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels. (2010) (51)
- Is Serum Albumin An Index of Nutritional Status in Continuous Ambulatory Peritoneal Dialysis Patients? (1994) (50)
- Increased expression of pro‐inflammatory genes in abdominal subcutaneous fat in advanced chronic kidney disease patients (2011) (50)
- Essential polyunsaturated fatty acids, inflammation and mortality in dialysis patients. (2012) (50)
- POOR NUTRITIONAL STATUS AND INFLAMMATION: Novel Approaches in an Integrated Therapy of Inflammatory‐Associated Wasting in End‐Stage Renal Disease (2004) (49)
- A comparative analysis of mass transport models in peritoneal dialysis. (1991) (48)
- Adipose tissue and inflammation in chronic kidney disease. (2006) (48)
- Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre. (2005) (48)
- Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients. (2015) (48)
- European best practice guidelines for peritoneal dialysis. 8 Nutrition in peritoneal dialysis. (2005) (47)
- Does persistent infection with Chlamydia pneumoniae increase the risk of atherosclerosis in chronic renal failure? (1999) (47)
- Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy. (2004) (46)
- Diffusive and convective solute transport in peritoneal dialysis with glucose as an osmotic agent. (1995) (46)
- Methods for Estimation of Peritoneal Dialysate Volume and Reabsorption Rate Using Macromolecular Markers (1994) (46)
- Hyaluronan decreases peritoneal fluid absorption in peritoneal dialysis. (1997) (46)
- Simple Models for Fluid Transport during Peritoneal Dialysis (1996) (45)
- Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume. (1998) (45)
- Diverticular disease of the colon: a risk factor for peritonitis in continuous peritoneal dialysis. (1990) (44)
- Determination of High and Low Molecular Weight Molecules of Icodextrin in Plasma and Dialysate, Using Gel Filtration Chromatography, in Peritoneal Dialysis Patients (2005) (43)
- Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease? (2006) (43)
- Malnutrition and inflammation are associated with impaired pulmonary function in patients with chronic kidney disease. (2004) (43)
- The Role of the TGF/Smad Signaling Pathway in Peritoneal Fibrosis Induced by Peritoneal Dialysis Solutions (2008) (42)
- Oxidative DNA Damage and Mortality in Hemodialysis and Peritoneal Dialysis Patients (2015) (42)
- Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients. (2013) (41)
- Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients. (2006) (41)
- Simple Membrane Models for Peritoneal Dialysis Evaluation of Diffusive and Convective Solute Transport (1992) (41)
- Vertebral bone density associates with coronary artery calcification and is an independent predictor of poor outcome in end-stage renal disease patients. (2016) (40)
- Peritoneal Transport during Dialysis with Amino Acid-Based Solutions (1993) (39)
- What is the Link between Poor Ultrafiltration and Increased Mortality in Anuric Patients on Automated Peritoneal Dialysis? Analysis of Data from Eapos (2006) (39)
- Six Years’ Experience of CAPD at One Centre: A Survey of Major Findings (1988) (39)
- Dialysis modality and nutritional status are associated with variability of inflammatory markers. (2016) (38)
- Changes in fat mass after initiation of maintenance dialysis is influenced by the uncoupling protein 2 exon 8 insertion/deletion polymorphism. (2006) (38)
- Circulating follistatin in patients with chronic kidney disease: implications for muscle strength, bone mineral density, inflammation, and survival. (2011) (37)
- Oral health and pro-inflammatory status in end-stage renal disease patients. (2007) (37)
- Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease. (2009) (37)
- Subclinical versus overt obesity in dialysis patients: more than meets the eye. (2013) (37)
- Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease (2018) (37)
- European best practice guidelines for peritoneal dialysis. 2 The initiation of dialysis. (2005) (37)
- Nonthyroidal illness: a risk factor for coronary calcification and arterial stiffness in patients undergoing peritoneal dialysis? (2013) (37)
- Hyaluronan decreases peritoneal fluid absorption: effect of molecular weight and concentration of hyaluronan. (1999) (37)
- Paradoxes in Peritoneal Transport of Small Solutes (1996) (36)
- Residual renal function, peritoneal transport characteristics and dialysis adequacy in peritoneal dialysis. (1996) (36)
- Educating end-stage renal disease patients on dialysis modality selection (2010) (34)
- The Use of Estimated Glomerular Filtration Rate for Dose Adjustment of Medications in the Elderly (2014) (34)
- Effects of intraperitoneal heparin on peritoneal transport in a chronic animal model of peritoneal dialysis. (2001) (34)
- Peritoneal ultrafiltration and fluid reabsorption during peritoneal dialysis. (1989) (32)
- Enhanced RAGE-mediated NFkappaB stimulation in inflamed hemodialysis patients. (2005) (32)
- Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients (2019) (32)
- Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy. (2006) (32)
- Peritonitis during Continuous Ambulatory Peritoneal Dialysis (CAPD): Risk Factors, Clinical Severity, and Pathogenetic Aspects (1988) (32)
- Determinants and survival implications of low bone mineral density in end-stage renal disease patients. (2013) (32)
- Does the ob gene product leptin stimulate erythropoiesis in patients with chronic renal failure? (1998) (31)
- IGF-1 and survival in ESRD. (2014) (31)
- Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease (2016) (30)
- Influence of nutritional status on plasma and erythrocyte sulphur amino acids, sulph-hydryls, and inorganic sulphate in end-stage renal disease. (2002) (30)
- Effect of peritonitis on peritoneal transport characteristics: glucose solution versus polyglucose solution. (2000) (30)
- Maintenance of optimal nutrition in CAPD. (1994) (29)
- Peroxisome proliferator-activated receptor γ polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement therapy (2005) (29)
- Daily exposure to dialysis fluid results in changes in peritoneal transport. (1997) (29)
- Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly (2015) (29)
- Adequacy Targets Can be Met in Anuric Patients by Automated Peritoneal Dialysis: Baseline Data from Eapos (2001) (29)
- Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammation (2012) (29)
- Associations of VEGF and its receptors sVEGFR-1 and -2 with cardiovascular disease and survival in prevalent haemodialysis patients. (2009) (29)
- Health-related quality of life as predictor of mortality in end-stage renal disease patients: an observational study (2019) (28)
- Effect of alternative osmotic agents on peritoneal transport. (1993) (28)
- Bone Mineral Density in End-Stage Renal Disease Patients: Association with Wasting, Cardiovascular Disease and Mortality (2008) (28)
- Is Fetuin-A/α2-Heremans-Schmid Glycoprotein Associated with the Metabolic Syndrome in Patients with Chronic Kidney Disease? (2008) (28)
- Influence of different treatments and schedules on the factors conditioning the nutritional status in dialysis patients. (1998) (28)
- Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis (2017) (27)
- Low levels of IgM antibodies against phosphorylcholine-A increase mortality risk in patients undergoing haemodialysis. (2009) (27)
- Elevated serum 8-oxo-dG in hemodialysis patients: a marker of systemic inflammation? (2006) (27)
- Evaluation of an experimental rat model for peritoneal dialysis: fluid and solute transport characteristics. (1994) (26)
- Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease (2018) (26)
- Interleukin-1 Gene Cluster Polymorphisms Are Associated with Nutritional Status and Inflammation in Patients with End-Stage Renal Disease (2005) (26)
- N-Terminal Pro-Brain Natriuretic Peptide Independently Predicts Protein Energy Wasting and Is Associated with All-Cause Mortality in Prevalent HD Patients (2008) (26)
- Icodextrin Metabolism and Alpha-Amylase Activity in Nonuremic Rats Undergoing Chronic Peritoneal Dialysis (2007) (25)
- Peritoneal Fluid and Solute Transport with Different Polyglucose Formulations (1998) (25)
- Lung Dysfunction and Mortality in Patients with Chronic Kidney Disease (2018) (25)
- What are the causes of protein-energy malnutrition in chronic renal insufficiency? (2002) (25)
- Peritoneal clearance of leptin in CAPD patients: impact of local insulin administration. (1999) (25)
- Temporal discrepancies in the association between the apoB/apoA‐I ratio and mortality in incident dialysis patients (2009) (24)
- Bidirectional Solute Transport in Peritoneal Dialysis (1994) (24)
- European best practice guidelines for peritoneal dialysis. 6 Automated peritoneal dialysis. (2005) (24)
- Plasma fatty acids in chronic kidney disease: nervonic acid predicts mortality. (2012) (24)
- Determination of α-Amylase Activity in Serum and Dialysate from Patients Using Icodextrin-Based Peritoneal Dialysis Fluid (2003) (24)
- Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study (2019) (23)
- Uraemic symptom burden and clinical condition in women and men of ≥65 years of age with advanced chronic kidney disease: results from the EQUAL study. (2018) (23)
- Influence of variation at the apolipoprotein E locus on lipid and lipoprotein levels in CAPD patients. (1997) (22)
- The Effect of Dialysate Acidity on Peritoneal Solute Transport in the Rat (1995) (22)
- Increased Levels of Modified Advanced Oxidation Protein Products Are Associated with Central and Peripheral Blood Pressure in Peritoneal Dialysis Patients (2015) (21)
- Fluid and Solute Transport in CAPD Patients before and after Permanent Loss of Ultrafiltration Capacity (2005) (21)
- Self-rated appetite as a predictor of mortality in patients with stage 5 chronic kidney disease. (2013) (21)
- Albumin and Amino Acid Levels as Markers of Adequacy in Continuous Ambulatory Peritoneal Dialysis (1994) (21)
- Variations in C-reactive protein during a single haemodialysis session do not associate with mortality. (2010) (20)
- Being an inflamed peritoneal dialysis patient - a Dante's journey. (2006) (20)
- Subclinical Atherosclerosis, Endothelial Function, and Serum Inflammatory Markers in Chronic Kidney Disease Stages 3 to 4 (2014) (20)
- Adipokines in Chronic Kidney Disease — Fat Tissue Gives Nephrologists a Message (2005) (19)
- Inverse J-shaped relation between coronary arterial calcium density and mortality in advanced chronic kidney disease. (2018) (19)
- Buffer transport in peritoneal dialysis. (2003) (19)
- Associations between the CYBA 242C/T and the MPO –463G/A Polymorphisms, Oxidative Stress and Cardiovascular Disease in Chronic Kidney Disease Patients (2007) (19)
- Retraining for prevention of peritonitis in peritoneal dialysis patients: A randomized controlled trial (2020) (19)
- Clinical determinants and mortality predictability of stearoyl‐CoA desaturase‐1 activity indices in dialysis patients (2013) (18)
- Bone mineral density at different sites and 5 years mortality in end-stage renal disease patients: A cohort study. (2019) (18)
- Physiological Saline is not a Biocompatible Peritoneal Dialysis Solution (1999) (18)
- Time dependence of solute removal during a single exchange. (1997) (17)
- Beyond the membrane--the role of new PD solutions in enhancing global biocompatibility. (2003) (17)
- Expression of osteoprotegerin in human fat tissue; implications for chronic kidney disease (2011) (17)
- Discriminative Impact of Ultrafiltration on Peritoneal Protein Transport (2000) (17)
- Serum Retinol-Binding Protein Concentration and Its Association with Components of the Uremic Metabolic Syndrome in Nondiabetic Patients with Chronic Kidney Disease Stage 5 (2008) (17)
- Influence of the CYP2D6 polymorphism and hemodialysis on codeine disposition in patients with end-stage renal disease (2010) (16)
- Place of genotyping and phenotyping in understanding and potentially modifying outcomes in peritoneal dialysis patients. (2006) (16)
- Nutritional Problems in Peritoneal Dialysis: An Overview (1999) (15)
- The Negative Results of the Ademex Study may be Positive for Peritoneal Dialysis. Time for a Paradigm Shift in the Focus of Peritoneal Dialysis Adequacy? (2002) (15)
- Determinants of Fibroblast Growth Factor-23 and Parathyroid Hormone Variability in Dialysis Patients (2013) (15)
- The future of European Nephrology ‘Guidelines’—a declaration of intent by European Renal Best Practice (ERBP) (2009) (15)
- European best practice guidelines for peritoneal dialysis. 5 Peritoneal dialysis solutions. (2005) (15)
- Heat sterilization of peritoneal dialysis solutions influences ingestive behavior in non-uremic rats. (2002) (14)
- Suboptimal dialysis initiation is associated with comorbidities and uraemia progression rate but not with estimated glomerular filtration rate (2020) (14)
- Serum 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, is associated with mortality independent of inflammation in chronic kidney disease. (2019) (14)
- Obesity on PD patients: causes and management. (2003) (14)
- European best practice guidelines for peritoneal dialysis. 9 PD and transplantation. (2005) (14)
- European best practice guidelines for peritoneal dialysis. 4 Continuous ambulatory peritoneal dialysis delivery systems. (2005) (13)
- Recovery of Renal Function after One-Year of Dialysis Treatment: Case Report and Registry Data (2010) (13)
- Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients (2018) (13)
- Adipokine signaling in the peritoneal dialysis patient. (2006) (13)
- A cohort study of insulin-like growth factor 1 and mortality in haemodialysis patients (2015) (12)
- Peritoneal Dialysis Prescription for Diabetic Patients (2005) (12)
- The enigma of decreased creatinine generation in acute kidney injury. (2012) (12)
- Three-month variation of plasma pentraxin 3 compared with C-reactive protein, albumin and homocysteine levels in haemodialysis patients (2014) (12)
- Elevated Circulating S100A12 Associates with Vascular Disease and Worse Clinical Outcome in Peritoneal Dialysis Patients (2016) (11)
- Delta-He: a novel marker of inflammation predicting mortality and ESA response in peritoneal dialysis patients (2014) (11)
- Peroxisome proliferator-activated receptor gamma polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement therapy. (2005) (11)
- Why do physicians prescribe dialysis? A prospective questionnaire study (2017) (11)
- Peroxisome Proliferator-Activated Receptor-γ Agonists Diminish Peritoneal Functional and Morphological Changes Induced by Bioincompatible Peritoneal Dialysis Solution (2006) (10)
- Rate of Synthetic Oligosaccharide Degradation as a Novel Measure of Amylase Activity in Peritoneal Dialysis Patients (2008) (10)
- High peritoneal residual volume decreases the efficiency of peritoneal dialysis. (1999) (10)
- Serum hepatocyte growth factor is associated with truncal fat mass and increased mortality in chronic kidney disease stage 5 patients with protein-energy wasting. (2015) (10)
- Chronic inflammation in PD patients. (2003) (10)
- Bicarbonate-Based Peritoneal Dialysis Solution has Less Effect on Ingestive Behavior than Lactate-Based Peritoneal Dialysis Solution (2009) (10)
- Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients (2019) (9)
- Functional vitamin K insufficiency, vascular calcification and mortality in advanced chronic kidney disease: A cohort study (2021) (9)
- The effect of dialysis modality on phosphate control : haemodialysis compared to haemodiafiltration – The Pan Thames Renal Audit (2010) (9)
- Immunoglobulin (Ig)M antibodies against oxidized cardiolipin but not native cardiolipin are novel biomarkers in haemodialysis patients, associated negatively with mortality (2013) (8)
- Determinants of N-Terminal Pro-Brain Natriuretic Peptide Variation in Hemodialysis Patients and Prediction of Survival (2014) (8)
- Molecular genetics in renal medicine: what can we hope to achieve? (2002) (8)
- The enigma of increasing serum leptin levels during peritoneal dialysis. (1999) (8)
- The Effect of Icodextrin-Based Solutions on Peritoneal Transport in Rats Undergoing Chronic Peritoneal Dialysis (2001) (8)
- Chapter 4 – Uremic Toxicity (2013) (8)
- Plasma Beta-Trace Protein as a Marker of Residual Renal Function: The Effect of Different Hemodialysis Modalities and Intra-Individual Variability over Time (2017) (8)
- Choice of dialysis modality among patients initiating dialysis: results of the Peridialysis study (2020) (8)
- Mathematical Modeling of the Glucose-Insulin System During Peritoneal Dialysis With Glucose-Based Fluids (2011) (8)
- Reply to A Molfino et al (2007) (7)
- Nutritional Aspects of Adult Patients Treated With Chronic Peritoneal Dialysis Aspectos Nutricionais de Pacientes Adultos em Diálise Peritoneal (2006) (7)
- Protein-Energy Malnutrition/Wasting During Peritoneal Dialysis (2009) (7)
- Copeptin is independently associated with vascular calcification in chronic kidney disease stage 5 (2020) (7)
- Chapter 25 – Peritoneal Physiology (2005) (7)
- Albumin-based solutions for peritoneal dialysis: investigations with a rat model. (1995) (7)
- Peritoneal dialysis patient selection from a comorbidity perspective (2020) (7)
- Intraperitoneal Addition of Hyaluronan Improves Peritoneal Dialysis Efficiency (1999) (7)
- A novel bioactive haemodialysis system using dissolved dihydrogen (H 2 ) produced by water electrolysis: a clinical trial (2010) (7)
- Statins to Treat Chronic Inflammation in Dialysis Patients — is this Feasible? (2007) (7)
- Serum Glutaredoxin Activity as a Marker of Oxidative Stress in Chronic Kidney Disease: A Pilot Study (2018) (7)
- Vasodilatation by intraperitoneal addition of nitroprusside is not a model for high peritoneal transport. (1999) (7)
- A genome-wide association study suggests correlations of common genetic variants with peritoneal solute transfer rates in patients with kidney failure receiving peritoneal dialysis. (2021) (6)
- Lipid disorders, statins and the peritoneal membrane. (2009) (6)
- How should we measure peritoneal dialysis adequacy in the clinic. (2009) (6)
- Intraperitoneal atrial natriuretic peptide increases peritoneal fluid and solute removal. (2001) (6)
- Cost-Effectiveness Analysis of Patiromer in Combination with Renin–Angiotensin–Aldosterone System Inhibitors for Chronic Kidney Disease in Sweden (2020) (6)
- Blood–brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins (2022) (5)
- Peritoneal transport with icodextrin solution. (2006) (5)
- Prevention and treatment of the malnutrition, inflammation and atherosclerosis (MIA) syndrome in uremic patients. (2000) (5)
- Selection of Genetic and Phenotypic Features Associated with Inflammatory Status of Patients on Dialysis Using Relaxed Linear Separability Method (2014) (5)
- A Simple and Fast Method to Estimate Peritoneal Membrane Transport Characteristics Using Dialysate Sodium Concentration (1999) (5)
- New Strategies for Management of Malnutrition in Peritoneal Dialysis Patients (2000) (5)
- Amphotericin B does not increase peritoneal fluid removal. (1998) (5)
- Longitudinal genome-wide DNA methylation changes in response to kidney failure replacement therapy (2022) (5)
- Dioctyl sodium sulphosuccinate increases net ultrafiltration in peritoneal dialysis. (1997) (5)
- Sieving coefficients for small solutes during experimental peritoneal dialysis in rats. (1995) (5)
- Sparing effect of peritoneal dialysis vs hemodialysis on BMD changes and its impact on mortality (2020) (5)
- Malnutrition in Patients with End-Stage Renal Disease - Anorexia,Cachexia and Catabolism (2007) (5)
- Fluid and Solute Transport using Different Sodium Concentrations in Peritoneal Dialysis Solutions (2001) (5)
- Association of Longitudinal High-Sensitivity Troponin T With Mortality in Patients With Chronic Kidney Disease. (2022) (4)
- Statins and lipid-lowering strategies in PD. (2012) (4)
- High-sensitivity troponins in dialysis patients: variation and prognostic value (2020) (4)
- European best practice guidelines for peritoneal dialysis. 1 General guidelines. (2005) (4)
- Ultrafiltration Failure in Peritoneal Dialysis Patients (2004) (4)
- Association between oestrogen receptor alpha gene polymorphism and mortality in female end-stage renal disease patients. (2007) (4)
- Lipid disorders, statins and the peritoneal membrane. (2009) (4)
- Influence of Erythropoiesis-Stimulating Agents on Glycated Hemoglobin in Nondiabetic Kidney Diseases at the Start of Dialysis (2010) (4)
- FP411THE ASSOCIATION BETWEEN RENAL FUNCTION AND TROPONIN T OVER TIME IN STABLE CKD PATIENTS (2019) (3)
- How should we measure peritoneal dialysis adequacy in the clinic. (2009) (3)
- Non-thyroidal illness: a risk factor for coronary calcification and arterial stiffness in patients undergoing peritoneal dialysis? (2014) (3)
- Dietary Requirements in Peritoneal Dialysis (1997) (3)
- Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study (2021) (3)
- Peritoneal Physiology (2010) (3)
- Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study (2021) (3)
- Epidemiology and outcome - 2 (2009) (3)
- Cardiovascular complications - 3 (2009) (2)
- Lipoprotein Lipase 1595 C/G and Hepatic Lipase –480 C/T Polymorphisms – Impact on Lipid Profile in Incident Dialysis Patients (2008) (2)
- The 12th International Conference on Continuous Renal Replacement Therapies (CRRT). March 7–10, 2007, San Diego, Calif. (2007) (2)
- MO058PREVENTION OF PERITONITIS IN PATIENTS WITH PERITONEAL DIALYSIS - EFFECTS OF REGULAR, TARGETED FOLLOW-UP OF PATIENTS´ THEORETICAL KNOWLEDGE AND PRACTICAL SKILLS WITH FOCUS ON INFECTION PROPHYLAXIS (PEPS) - A RANDOMIZED, CONTROLLED TRIAL (2017) (2)
- Peritoneal transport and EPO (1994) (2)
- The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease (2021) (2)
- First-year mortality in incident dialysis patients: results of the Peridialysis study (2021) (2)
- Can plasma cystatin C level be used to estimate residual renal function in patients on dialysis? (2007) (2)
- Nutrition and clinical outcome in peritoneal dialysis patients. (1999) (2)
- Protein-energy wasting, inflammation and oxidative stress (2009) (1)
- Introduction: BUFFER SYSTEMS AND BIOCOMPATIBILITY IN PERITONEAL DIALYSIS (2003) (1)
- Chapter 26 – Peritoneal Physiology (2010) (1)
- Acknowledgement to Referees (2006) (1)
- Peritoneal fluid kinetics: comparison between polyglucose solution and albumin solution. (1999) (1)
- Epidemiology and outcome research in CKD 5D (2012) (1)
- [Choose the right method fo estimation of kidney function. The nature of the problem determines which method should be used]. (2009) (1)
- Continuous Renal Replacement Therapies (1995) (1)
- P300 MUSCLE ATROPHY, INFLAMMATION AND CLINICAL OUTCOME IN INCIDENT AND PREVALENT DIALYSIS PATIENTS (2008) (1)
- MP666INFLAMMATION DOWN REGULATES CYTOCHROME P450 MEDINATED DRUG METABOLISM IN HEMODIALYSIS PATIENTS (2016) (1)
- A new, safe and convenient 5-L dual-chamber container for automated peritoneal dialysis. (2011) (1)
- Protein-energy wasting, inflammation and oxidative stress (2009) (1)
- European guidelines on when to start dialysis: check the facts first before commenting. (2012) (1)
- Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients (2022) (1)
- [Medical and human aspects interact in dignified withdrawal of dialysis treatment]. (1991) (1)
- Peritoneal dialysis - clinical (2013) (1)
- FP649CAUSES OF UNPLANNED DIALYSIS INITIATION: RESULTS OF THE NORDIC PERIDIALYSIS STUDY (2018) (1)
- Low plasma insulin-like growth factor-1 associates with increased mortality in chronic kidney disease patients with reduced muscle strength. (2022) (1)
- [Drug dosage should be based on renal function]. (2013) (1)
- Inverse association of transferrin saturation with mortality risk in chronic kidney disease (2020) (1)
- Do metabolic derangements in end‐stage polycystic kidney disease differ versus other primary kidney diseases? (2018) (1)
- Nutritional management of chronic peritoneal dialysis patients (2022) (0)
- [Unequal access to health care in the country: assisted peritoneal dialysis not offered to all who need it]. (2012) (0)
- P0941HEALTHY K-RICH DIET IN CHRONIC KIDNEY DISEASE (CKD) PATIENTS USING SODIUM ZIRCONIUM CYCLOSILICATE (SZC) TO CONTROL HYPERKALEMIA: A FEASIBILITY STUDY (HELPFUL) (2020) (0)
- MO580: Healthy Plant-Based Diet for Patients With Chronic Kidney Disease (CKD) Through Use of Sodium Zirconium Cyclosilicate (SZC): A Feasibility Study (Helpful) (2022) (0)
- Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients (2018) (0)
- List of Contributors (2019) (0)
- OP-NDTJ200001 1157..1162 (2020) (0)
- Longitudinal genome-wide DNA methylation changes in response to kidney failure replacement therapy (2022) (0)
- MO681: Association of Framingham Risk Score with Mortality in Kidney Failure Patients from China and Sweden (2022) (0)
- P1131STEADY CONCENTRATION PERITONEAL DIALYSIS INCREASES ULTRAFILTRATION AND SODIUM REMOVAL COMPARED TO CAPD (2020) (0)
- SP019IS END-STAGE POLYCYSTIC KIDNEY DISEASE ASSOCIATED WITH IMPAIRMENT OF GLUCOSE METABOLISM? (2016) (0)
- Subject Index Vol. 26, 2008 (2008) (0)
- FP392DYNAMIC PREDICTION OF MORTALITY IN ADVANCED CKD USING TROPONIN T (2019) (0)
- Acknowledgement to Reviewers (2010) (0)
- FP559ELEVATED CIRCULATING S100A12 ASSOCIATES WITH VASCULAR DISEASE AND CLINICAL OUTCOME IN PERITONEAL DIALYSIS PATIENTS (2015) (0)
- SP242GLOMERULAR FILTRATION RATE ESTIMATION USING BETA TRACE PROTEIN: EXTERNAL VALIDATION OF THREE EQUATIONS (2016) (0)
- MP528SKIN AUTOFLUORESCENCE (SAF), A MARKER OF TISSUE ADVANCED GLYCATED END-PRODUCTS (AGE), AND ARTERIAL STIFFNESS IN PERITONEAL DIALYSIS PATIENTS (2016) (0)
- Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammation (2011) (0)
- Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease (2012) (0)
- FP336HIGHER NEUTROPHIL TO LYMPHOCYTE RATIO ASSOCIATES WITH POOR CLINICAL OUTCOME IN CKD5 PATIENTS (2018) (0)
- [It is better use a modern formula than being formal]. (2013) (0)
- Subject Index Vol. 24, 2006 (2006) (0)
- CKD NUTRITION, INFLAMMATION AND OXIDATIVE STRESS (2014) (0)
- MO445BRAIN AND GUT AXIS IN CHRONIC KIDNEY DISEASE: FOCUS ON SPECIFIC BIOMARKERS, AND TIGHT JUNCTION PROTEINS (2021) (0)
- Treatment practices and outcomes in incident peritoneal dialysis patients: the Swedish Renal Registry 2006–2015 (2021) (0)
- P0669HIGH ESTIMATED PHENOTYPIC AGE ASSOCIATES WITH WORSE CLINICAL OUTCOME IN CHRONIC KIDNEY DISEASE PATIENTS (2020) (0)
- [Peritoneal dialysis-associated peritonitis caused by Rhizobium species - a case report]. (2022) (0)
- Subject Index Vol. 29, 2009 (2009) (0)
- PP111-MON SERUM ALBUMIN (S-ALB) AS PREDICTOR OF NUTRITIONAL STATUS AND MORTALITY IN END-STAGE RENAL DISEASE (ESRD) PATIENTS (PTS) (2011) (0)
- Gene Expression Analysis in Inflamed and Non-inflamed Hemodialysis (HD) Patients Using a cDNA Microarray (2003) (0)
- Jonas Bergström, MD, PHD (1929-2001): Scientist, Physician, Researcher, Mentor, Musician, and Friend (2001) (0)
- The role of peritoneal dialysis in renal replacement therapy: an update on medical aspects. (2005) (0)
- Paradoxes in Peritoneal Transport of Small Solutes (1996) (0)
- How to Assess Peritoneal Transport: Which Test Should We Use? (2009) (0)
- Cardiovascular complications of CKD 2 vi 311 Cardiovascular complications of CKD 2 SaP 234 (2007) (0)
- How to assess peritoneal transport: which test should we use? (2009) (0)
- Reply to ‘Depression and clinical outcomes in CKD: do anti-depressants play a role? (EQUAL Study)’ (2022) (0)
- Peritoneal dialysis (2013) (0)
- Book Review: Lymphatic and Non-Lymphatic Fluid Loss from the Peritoneal Cavity (1994) (0)
- Blood pressure and kidney outcomes in patients with severely decreased glomerular filtration rate: a nationwide observational cohort study (2022) (0)
- FC020BONE MINERAL DENSITY AT VARIOUS SITES VERSUS MORTALITY IN END-STAGE RENAL DISEASE (ESRD) (2019) (0)
- Telomere shortening, a new mortality risk factor in dialysis patients. Associations with inflammatory markers and fetuin-a levels (2007) (0)
- SP402PENTOSIDINE IN END-STAGE RENAL DISEASE PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) VERSUS OTHER ETIOLOGIES (2019) (0)
- PP112-MON SELF-RATED APPETITE IS A POOR PREDICTOR OF MORTALITY IN PRE-DIALYSIS AND DIALYSIS PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) (2011) (0)
- Education of ESRD patients on dialysis modality selection: 'intensive haemodialysis first': reply (2010) (0)
- Plasma Lipoprotein(a) Is Related to Peritoneal Albumin Losses (1997) (0)
- ’ s response to reviews Title : Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients (2019) (0)
- SP298HIGHER MEAN CORPUSCULAR VOLUME ASSOCIATES WITH POOR CLINICAL OUTCOME IN CKD5 PATIENTS (2018) (0)
- [Dialysis is life-sustaining--but when to initiate it?]. (2002) (0)
- MO035INFLAMMATION MODIFIES THE MORTALITY PREDICTIVE CAPACITY OF OXIDATIVE DNA DAMAGE IN CHRONIC KIDNEY DISEASE PATIENTS (2017) (0)
- MP311 EFFECT OF INCREASED ULTRAFILTRATION ON B-TYPE NATRIURETIC PEPTIDE (BNP) AND C-REACTIVE PROTEIN (CRP): DOES HYPERVOLEMIA MEDIATES CARDIAC DYSFUNCTION AND INFLAMMATION IN HEMODIALYSIS (2005) (0)
- Contents, Vol. 13, 1995 (1993) (0)
- Contents Vol. 24, 2006 (2006) (0)
- TO024COMBINATION OF GENOTYPE AND PHENOTYPE FEATURES AS PREDICTORS OF INFLAMMATION, CARDIOVASCULAR DISEASE AND PROTEIN ENERGY WASTING IN PATIENTS WITH CHRONIC KIDNEY DISEASES (2017) (0)
- FO055EVALUATION OF PREDICTION MODELS FOR PROGRESSION OF CHRONIC KIDNEY DISEASE TO KIDNEY FAILURE: A COMPREHENSIVE EXTERNAL VALIDATION STUDY (2019) (0)
- MP429SUBJECTIVE GLOBAL ASSESSMENT OF NUTRITIONAL STATUS AS PREDICTOR OF MORTALITY IN CHRONIC KIDNEY DISEASE PATIENTS (2017) (0)
- Department of Clinical Sciences Interventions and Technology (CLINTEC) Karolinska Institutet, Stockholm, Sweden VASCULAR AND INFLAMMATORY MARKERS IN CHRONIC KIDNEY DISEASE (2015) (0)
- MP440OBSTRUCTIVE AND RESTRICTIVE LUNG FUNCTION ASSOCIATES WITH INCREASED MORTALITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE (2017) (0)
- No association between plasma total homocysteine and common carotid intima thickness in end-stage renal disease patients (2002) (0)
- Factors associated with time to first dialysis-associated peritonitis episode: Data from the Peritonitis Prevention Study (PEPS). (2023) (0)
- Outcome of atrial fibrillation among patients with end-stage renal disease (2010) (0)
- SP286PLASMA BETA TRACE PROTEIN PREDICTS MORTALITY IN CKD: RELATION WITH ENDOTHELIAL DYSFUNCTION (2016) (0)
- SO059CIRCULATING PROTEINS AS PREDICTORS OF CARDIOVASCULAR MORTALITY IN END-STAGE RENAL DISEASE PATIENTS ON HEMODIALYSIS - A PROTEOMIC APPROACH (2017) (0)
- SP564HIGH SENSITIVE TROPONIN T AND TROPONIN I THREE MONTH VARIATION IN PREVALENT HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS (2015) (0)
- Treatment of malnutrition and anaemia (2011) (0)
- P1399SPARING EFFECT OF PERITONEAL DIALYSIS VS HEMODIALYSIS ON CHANGE OF BONE MINERAL DENSITY EVALUATED BY WHOLE-BODY DXA AFTER INITIATION OF DIALYSIS THERAPY AND ITS IMPACT ON CLINICAL OUTCOME (2020) (0)
- P0714RELATIONSHIP BETWEEN BIOLOGICAL AGE ESTIMATED BY SKIN AUTOFLUORESCENCE, CHRONOLOGICAL AGE, AND MORTALITY IN CHRONIC KIDNEY DISEASE (2020) (0)
- Nephrology in Sweden (2021) (0)
- Protein-energy wasting, inflammation and oxidative stress in CKD 5D (2011) (0)
- MP383LOW BONE MINERAL DENSITY OF LEGS AND FEMORAL NECK ASSOCIATES WITH CORONARY CALCIFICATION SCORE IN FEMALE END-STAGE RENALDISEASE PATIENTS (2016) (0)
- MO445 BRAIN AND GUT AXIS IN CHRONIC KIDNEY DISEASE: FOCUS ON SPECIFIC BIOMARKERS, AND TIGHT JUNCTION PROTEINS (2021) (0)
- Converting from face-to-face to postal follow-up and its effects on participant retention, response rates and errors: lessons from the EQUAL study in the UK (2021) (0)
- Subject Index Vol. 13, 1995 (1995) (0)
- Contents Vol. 29, 2009 (2009) (0)
- 24th Annual Meeting of the International Society of Blood Purification (ISBP). September 8–10, 2006, Nara, Japan (2006) (0)
- Systemic inflammation in hemodialysis patients is associated with increased oxidation of the nucleotide pool as revealed by serum levels of 8oxo-dG (2005) (0)
- SP356PULMONARY DYSFUNCTION IS LINKED TO MALNUTRITION AND INFLAMMATION IN CHRONIC KIDNEY DISEASE PATIENTS (2016) (0)
- The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease (2023) (0)
- Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability (2010) (0)
- SP323HIGH FIBRINOGEN LEVELS ARE INDEPENDENTLY ASSOCIATED WITH INCREASED MORTALITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) (2018) (0)
- [Dialysis treatment is satisfactory. A survey of all patients with chronic renal failure in Stockholm]. (1995) (0)
- Progression & risk factors CKD 1-5 (2) (2011) (0)
- CKD BONE DISEASE (2014) (0)
- MO673: Association of Mean Corpuscular Volume with Mortality in Kidney Failure Patients: Opposite Findings in Chinese and Swedish Kidney Failure Patients (2022) (0)
- Special Problems in Caring for Patients on Peritoneal Dialysis (2016) (0)
- Contents Vol. 26, 2008 (2008) (0)
- Central obesity as assessed by conicity index and a-body shape index associates with cardiovascular risk factors and mortality in kidney failure patients (2023) (0)
- FC064RISK FACTORS FOR UNPLANNED DIALYSIS INITIATION: FINAL RESULTS OF THE NORDIC PERIDIALYSIS STUDY (2019) (0)
- P1137FACTORS DETERMINING CHOICE OF DIALYSISI MODALITY AMONG PATIENTS INITIATING DIALYSIS. RESULTS OF THE PERIDIALYSIS STUDY (2020) (0)
- Peritoneal Dialysis (2012) (0)
- P0673INVERSE ASSOCIATION OF TRANSFERRIN SATURATION WITH MORTALITY RISK IN CHRONIC KIDNEY DISEASE (2020) (0)
- MO708: Association of Atherogenic Index of Plasma (AIP) with Mortality in Chinese and Swedish End-Stage Kidney Disease Patients: Results from Two Cohorts (2022) (0)
- FP580MUSCLE STRENGTH, MUSCLE MASS AND ARTERIAL STIFFNESS IN PERITONEAL DIALYSIS PATIENTS (2015) (0)
- P1160INCREASED REMOVAL RATES OF FLUID AND SODIUM DURING STEADY CONCENTRATION PERITONEAL DIALYSIS COMPARED TO ICODEXTRIN AND PERITONEAL EQUILIBRATION TEST (2020) (0)
- Anaemia in CKD 5D (2011) (0)
- Estimated hepatic and adipose tissue stearoyl-coa desaturase-1 activities are associated with inflammation and all-cause mortality in dialysis patients (2012) (0)
- P1448FACTORS ASSOCIATED WITH INCREASED MORTALITY AFTER DIALYSIS INITIATION. RESULTS OF THE PERIDIALYSIS STUDY (2020) (0)
- SP429CIRCULATING PLASMA PENTOSIDINE IN PRE-DIALYSIS, PRE-TRANSPLANT, PERITONEAL DIALYSIS (PD) AND HEMODIALYSIS (HD) PATIENTS (PTS) (2015) (0)
- Chronic Kidney Disease: Need for an Integrated Therapy Against Malnutrition and Wasting (2005) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Olof Heimbürger?
Olof Heimbürger is affiliated with the following schools: